Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310856850> ?p ?o ?g. }
- W4310856850 endingPage "e002135" @default.
- W4310856850 startingPage "e002135" @default.
- W4310856850 abstract "Cancer treatment with vascular endothelial growth factor signalling pathway (VSP) inhibitors frequently causes hypertension. Although previous reports suggested that the antihypertensive drug renin-angiotensin system inhibitor (RASI) may have a positive synergistic effect with VSP inhibitors, the actual impact on clinical outcomes is unknown.The study aims to clarify whether RASIs exhibit clinical benefits for patients with cancer with hypertension.From the Longevity Improvement and Fair Evidence Study database, comprising Japanese claims data between 2016 and 2020, we reviewed 2380 patients treated with VSP inhibitors who received antihypertensive treatment during cancer therapy. The patients were classified into two groups: with-RASI (n=883) and without-RASI (n=1497). In addition, 1803 of these patients treated for hypertension with RASI-only (n=707) or calcium channel blocker-only (n=1096) were also reviewed. The time-to-treatment failure (TTF), the interval from initiation of chemotherapy to its discontinuation, was applied as the primary endpoint.The median TTFs were 167 (60-382) days in the with-RASI group and 161 (63-377) days in the without-RASI group (p=0.587). All models, including Cox proportional hazard models and multiple propensity score models, did not reveal the superiority of with-RASI treatment. In the propensity score matching model, the HR for treatment with-RASI compared with that for without-RASI was 0.96 (95% CI 0.86 to 1.06, p=0.386). In addition, the TTFs of RASI-only were not superior to calcium channel blocker-only (p=0.584).RASIs for hypertension do not benefit clinical outcomes during cancer therapy with VSP inhibitors. In addition, RASIs and calcium channel blockers have comparable clinical efficacy as first-line antihypertensive." @default.
- W4310856850 created "2022-12-19" @default.
- W4310856850 creator A5001880794 @default.
- W4310856850 creator A5002444455 @default.
- W4310856850 creator A5005037745 @default.
- W4310856850 creator A5038542500 @default.
- W4310856850 creator A5045825106 @default.
- W4310856850 creator A5048711137 @default.
- W4310856850 creator A5060899645 @default.
- W4310856850 creator A5070901487 @default.
- W4310856850 creator A5072512404 @default.
- W4310856850 creator A5083634437 @default.
- W4310856850 creator A5085122354 @default.
- W4310856850 date "2022-12-01" @default.
- W4310856850 modified "2023-10-13" @default.
- W4310856850 title "Effect of renin–angiotensin system inhibitors in patients with cancer treated with anti-VEGF therapy" @default.
- W4310856850 cites W1511989356 @default.
- W4310856850 cites W1992146834 @default.
- W4310856850 cites W2017640925 @default.
- W4310856850 cites W2021968441 @default.
- W4310856850 cites W2024048778 @default.
- W4310856850 cites W2038827789 @default.
- W4310856850 cites W2040464123 @default.
- W4310856850 cites W2042113565 @default.
- W4310856850 cites W2051137473 @default.
- W4310856850 cites W2057780602 @default.
- W4310856850 cites W2070332557 @default.
- W4310856850 cites W2076017354 @default.
- W4310856850 cites W2083437069 @default.
- W4310856850 cites W2087759558 @default.
- W4310856850 cites W2091446228 @default.
- W4310856850 cites W2111092101 @default.
- W4310856850 cites W2111180661 @default.
- W4310856850 cites W2122724278 @default.
- W4310856850 cites W2128412585 @default.
- W4310856850 cites W2137816700 @default.
- W4310856850 cites W2159034771 @default.
- W4310856850 cites W2165446303 @default.
- W4310856850 cites W2166573361 @default.
- W4310856850 cites W2214318022 @default.
- W4310856850 cites W2609605008 @default.
- W4310856850 cites W2794931489 @default.
- W4310856850 cites W2894724600 @default.
- W4310856850 cites W2909932177 @default.
- W4310856850 cites W2915064532 @default.
- W4310856850 cites W2915976688 @default.
- W4310856850 cites W2931650530 @default.
- W4310856850 cites W3023529892 @default.
- W4310856850 cites W4238907867 @default.
- W4310856850 cites W4245194102 @default.
- W4310856850 cites W4283656419 @default.
- W4310856850 doi "https://doi.org/10.1136/openhrt-2022-002135" @default.
- W4310856850 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36600585" @default.
- W4310856850 hasPublicationYear "2022" @default.
- W4310856850 type Work @default.
- W4310856850 citedByCount "2" @default.
- W4310856850 countsByYear W43108568502023 @default.
- W4310856850 crossrefType "journal-article" @default.
- W4310856850 hasAuthorship W4310856850A5001880794 @default.
- W4310856850 hasAuthorship W4310856850A5002444455 @default.
- W4310856850 hasAuthorship W4310856850A5005037745 @default.
- W4310856850 hasAuthorship W4310856850A5038542500 @default.
- W4310856850 hasAuthorship W4310856850A5045825106 @default.
- W4310856850 hasAuthorship W4310856850A5048711137 @default.
- W4310856850 hasAuthorship W4310856850A5060899645 @default.
- W4310856850 hasAuthorship W4310856850A5070901487 @default.
- W4310856850 hasAuthorship W4310856850A5072512404 @default.
- W4310856850 hasAuthorship W4310856850A5083634437 @default.
- W4310856850 hasAuthorship W4310856850A5085122354 @default.
- W4310856850 hasBestOaLocation W43108568501 @default.
- W4310856850 hasConcept C121608353 @default.
- W4310856850 hasConcept C126322002 @default.
- W4310856850 hasConcept C17923572 @default.
- W4310856850 hasConcept C198710026 @default.
- W4310856850 hasConcept C207103383 @default.
- W4310856850 hasConcept C2776694085 @default.
- W4310856850 hasConcept C2778715236 @default.
- W4310856850 hasConcept C2780356492 @default.
- W4310856850 hasConcept C44249647 @default.
- W4310856850 hasConcept C50382708 @default.
- W4310856850 hasConcept C519063684 @default.
- W4310856850 hasConcept C71924100 @default.
- W4310856850 hasConcept C84393581 @default.
- W4310856850 hasConcept C98274493 @default.
- W4310856850 hasConceptScore W4310856850C121608353 @default.
- W4310856850 hasConceptScore W4310856850C126322002 @default.
- W4310856850 hasConceptScore W4310856850C17923572 @default.
- W4310856850 hasConceptScore W4310856850C198710026 @default.
- W4310856850 hasConceptScore W4310856850C207103383 @default.
- W4310856850 hasConceptScore W4310856850C2776694085 @default.
- W4310856850 hasConceptScore W4310856850C2778715236 @default.
- W4310856850 hasConceptScore W4310856850C2780356492 @default.
- W4310856850 hasConceptScore W4310856850C44249647 @default.
- W4310856850 hasConceptScore W4310856850C50382708 @default.
- W4310856850 hasConceptScore W4310856850C519063684 @default.
- W4310856850 hasConceptScore W4310856850C71924100 @default.
- W4310856850 hasConceptScore W4310856850C84393581 @default.
- W4310856850 hasConceptScore W4310856850C98274493 @default.